Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 1

Interventions

Specimen Handling 84Magnetic Resonance Spectroscopy 83Cyclophosphamide 77pembrolizumab 64Radiotherapy 58Nivolumab 55fludarabine 47Cisplatin 45Biopsy 41Carboplatin 40Standard of Care 36Dexamethasone 33Rituximab 30Radiation 30Bevacizumab 30Radiosurgery 29Temozolomide 28Gemcitabine 28Surveys and Questionnaires 27Doxorubicin 27Cytarabine 27Paclitaxel 26venetoclax 25fludarabine phosphate 25Blood Specimen Collection 25Practice Guidelines as Topic 24Ipilimumab 24Interviews as Topic 21Fluorouracil 21atezolizumab 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Valacyclovir × 30 days × Clear all
NCT06914479 2026-05-27

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

University of Michigan Rogel Cancer Center

Phase 1 Recruiting
11 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡